Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Pharmaceutics|January 21, 2024
Semi-crystalline materials for pharmaceutical fused filament fabrication: Dissolution and porosityS Henry, M Carroll, K N Murphy, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|October 14, 2020
A primary drying model-based comparison of conventional batch freeze-drying to continuous spin-freeze-drying for unit dosesL Leys, B Vanbillemont, P J Van Bockstal, et al.
European Journal of Cancer Care|September 29, 2022
Hospitalisations of patients with cancer in the last stage of life. Reason to improve advance care planning?Annemieke van der Padt-Pruijsten, Tanja Oostergo, Maria B L Leys, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 7, 2022
The effect of a palliative care pathway on medical interventions at the end of life: a pre-post-implementation studyAnnemieke van der Padt-Pruijsten, Maria B L Leys, Esther Oomen-de Hoop, et al.
Journal of Pain and Symptom Management|February 9, 2021
Effects of Implementation of a Standardized Palliative Care Pathway for Patients with Advanced Cancer in a Hospital: A Prospective Pre- and Postintervention StudyAnnemieke van der Padt-Pruijsten, Maria B L Leys, Esther Oomen-de Hoop, et al.
European Journal of Cancer Care|October 26, 2021
Quality of hospital discharge letters for patients at the end of life: A retrospective medical record reviewMarijanne Engel, Annemieke van der Padt-Pruijsten, Auke M T Huijben, et al.
British Journal of Cancer|January 26, 2005
A phase II study of raltitrexed and gemcitabine in patients with advanced pancreatic carcinomaJ J Arends, H P Sleeboom, M B L Leys, et al.
Vaccine|November 2, 2013
Serum antibody response to influenza virus vaccination during chemotherapy treatment in adult patients with solid tumoursM L Wumkes, A M T van der Velden, M Los, et al.
British Journal of Haematology|March 10, 2020
Bortezomib maintenance after R-CHOP, cytarabine and autologous stem cell transplantation in newly diagnosed patients with mantle cell lymphoma, results of a randomised phase II HOVON trialJeanette K Doorduijn, Josee M Zijlstra, Pieternella J Lugtenburg, et al.
Eclinicalmedicine|September 8, 2023
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trialKaz Groen, Claudia A M Stege, Kazem Nasserinejad, et al.
Pageof 2